INCTR's Biennial Meeting 2011

INCTR's Biennial Meeting will take place at the Best Western County House Hotel in Brussels on April 4-6th 2011. The major themes of this meeting will be pediatric cancer, palliative care and education and training of health professionals. The primary purpose of the meeting is to ensure that INCTR’s members and partners have an opportunity to discuss on-going or planned projects to further develop an interactive and integrated network for cancer control in developing countries.

Please click HERE to view the program for this meeting

For more information, please contact Cédric Petit-Musin (eb.rtcni|cirdec#eb.rtcni|cirdec)

flickr:5484842439

Please click here to view the program for this meeting.

INCTR Awards

INCTR gives two awards that are presented at the time of INCTR Biennial Meetings to individuals who have made outstanding contributions to cancer treatment or research in one or more developing countries.

The purpose of these awards is not simply to recognize and honor the recipients, but also to show, by their example, that much can be accomplished even when resources are limited. It is hoped that their work and philosophy, brought, through the award lectures, to a broader audience than would otherwise be the case, will inspire others to greater efforts.

Each of the awards is named after a distinguished oncologist. They began their careers when there so little knowledge about the causes of cancer, that people could only live in fear that they would one day be a victim, while the diagnosis was usually hidden from those unfortunate enough to develop cancer because so little could be done for them. It is thanks to the resolution and fortitude of Dr. Nazli Gad-el-Mawla, Dr. Paul P. Carbone and others like them, who worked through a time when cancer specialists were often accused of prolonging the misery of cancer victims through their efforts at treatment rather than helping them, that today, at least in the wealthier nations, more than half of those who develop cancer can be cured. Both Dr. Nazli and Dr. Carbone were responsible for training numerous young people, and so leave us a precious legacy through which their work will be continued.

The Nazli Gad-el-Mawla Award is given for outstanding contributions to cancer control by an individual from a country with limited resources.

Nazli Gad-el-Mawla, was a pioneer Egyptian oncologist, who, as a member of a small group of oncologists working at the National Cancer Institute in Cairo in the 1960s and ‘70s helped to build the institute into one of the premier cancer centers in the Middle East. She founded the Department of Medical Oncology in 1970 and, as part of it, developed a strong pediatric oncology program. She is known particularly for her work in the chemotherapy of cancer of the bilharzial bladder, which accounts for some 25% of all cancer in Egypt, and in hematological malignancies. She was highly respected both by her colleagues in Egypt and also by the international community of oncologists in which she became increasingly active throughout her career.

The 2011 Award recipient is Dr. Kunnambath Ramadas

The Paul P. Carbone Award in International Oncology is given for outstanding contributions to oncology or cancer research in one or more developing countries by an individual from a resource-rich country.

Paul P. Carbone was a pioneer American oncologist, who, as the Associate Director for the Clinical Oncology Program at the National Cancer Institute, Bethesda, played a critical role in the development of cancer chemotherapy. Subsequently, he continued his work as the Director of the Cancer Center at the University of Madison, Wisconsin. From the beginning, he recognized not only the needs of patients in developing countries, but also the contribution that scientific research conducted in such countries could and should make to the global efforts against cancer.

Dr. Carbone’s family have established the Paul P. Carbone MD Memorial Foundation (www.carbonefoundation.org) for the “support of scientific, educational, and charitable endeavors that reflect Dr. Carbone’s practice of the art and science of oncology and his lifelong dedication to teaching and mentoring”.

The 2011 Award recipient is Dr. Raul Ribeiro

flickr:5576081461 Dr. Kunnambath Ramadas, Recipient of the Nazli Gad-el-Mawla Award 2011

Dr. Ramadas has a MD degree in Radiation Oncology and is a fellow of the National Academy of Medical Sciences, India. He began his career in clinical oncology and cancer control in 1985 and has served in these capacities in various tertiary cancer care centres in India. In 1990, he joined the Regional Cancer Center (RCC), Thiruvananthapuram (Trivandrum), South India, which is a large comprehensive tertiary cancer center catering
to the needs of around 14,000 new cancer cases annually. Currently he is the Medical Superintendent and Chief of the Head and Neck Specialty Clinic at the RCC. He is a member of the Human Ethics Committees in various institutions in India and an active member of several professional groups.

Dr. Ramadas is the Indian Principal Investigator of the Trivandrum Oral and Breast Cancer Screening Projects, in collaboration with the International Agency for Research on Cancer (IARC), Lyon, France. The Trivandrum Oral Cancer Screening Project, initiated in 1995, has showed the effectiveness of visual screening in reducing mortality from oral cancer. This method is cost effective and can be integrated easily into the existing health care systems in many high risk countries, including India.

Dr. Ramadas is leading a population-based screening project to evaluate the effectiveness of physical examination in the control of breast cancer. He is also a leading investigator in several ongoing multi-centre research projects addressing the efficacy and safety of new treatment protocols for head and neck cancers.

He has made significant contributions in translational research, identifying molecular markers such as antiapototic genes, neo-vascularisation and various metabolic markers in predicting cancer progression and treatment response in head and neck cancers.

Dr. Ramadas has authored more than 60 medical articles, primarily in international journals. He has been the recipient of many honors and awards including the prestigious Visiting Scientist Award for Senior Scientists by IARC and the Best Doctor Award - 2006 in Cancer Control by the Government of Kerala, India.

flickr:5576081867 Dr. Raul Ribeiro, Recipient of the Paul P. Carbone Award in International Oncology 2011

Raul C. Ribeiro, M.D., leads several patient care and research efforts at St. Jude Children’s Research Hospital in Memphis, Tennessee, USA. St. Jude is internationally recognized for its pioneering research and treatment of
children with cancer and other catastrophic diseases.

Dr. Ribeiro directs the St. Jude International Outreach Program (IOP), an initiative to share knowledge, technology
and organizational skills worldwide in order to help increase childhood cancer cure rates. He is also the Leukemia/Lymphoma Division Director, the St. Jude Cancer Center’s Outreach Program Associate Director and a member of the Oncology Department. Dedicating his life to the fight against childhood cancer, Dr. Ribeiro has led
work that has resulted in a dramatic improvement in the survival rates of children with cancer around the globe.

Since taking the IOP helm in 1997, he has helped establish partnerships with 20 medical institutions in 15 countries. These partnership efforts include training pediatric oncologists and nurses to provide optimal clinical care.

In 2002, Dr. Ribeiro led the development of Cure4Kids (www.Cure4Kids.org), a free, online resource for continuing education about catastrophic childhood illnesses. The site promotes collaborative work spaces; training for better management of patient information; and online meetings for consultation and discussions of critical issues related to pediatric oncology and hematology. Today, the effort has thousands of registered users in more than 175 countries.

Dr. Ribeiro is a founding trustee of World Child Cancer and actively participates in the development of multiple international projects to promote cancer treatment in areas with poor resources and to improve the survival rates of children with cancer globally.

Apart from his work in developing countries, Dr. Ribeiro’s research interests include acute myeloid leukemia, acute lymphoblastic leukemia and adrenocortical carcinoma, an extremely rare childhood cancer. Additionally, Dr. Ribeiro and his colleagues created the International Pediatric Adrenocortical Tumor Registry, which has resulted in a better understanding of these tumors and the implementation of a multi-institutional treatment program.

Dr. Ribeiro has been an invited speaker at many universities, research institutions and international symposia and has authored numerous book chapters and articles.

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License